KLE Academy of Higher Education and Research (Deemed-to-be-University)
J N Medical College, Belgaum, Karnataka, India
Department of Respiratory Medicine

Research Projects 

Ongoing

Sl No Principal Investigator Co-Principal Investigator Title of the Project Funding Agency  Duration  (From-To)  Clinical Trial Registration Details  if any Status
1 Dr. Jyothi Hattiholi     – A Phase 3 , Multicentre, Randomised, Double-blind, Chronic-dosing, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Two Dose Regimens of MEDI13506 in Participants with Symptomatic Chronic Obstructive Pulmonary Diseas (COPD) with a History of COPD Exacerbations (OBERON) AstraZeneca  –  – on going
2 Dr. Jyothi Hattiholi     – A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicentre 24 to 52 Week Veriable Length Study to Assess the Efficacy and Safety of Budesonide, Glycopyrronium, and Formoterol Fumarate Meterd Dose Inhaler (MDI) Relative to Budesonide and Formoterol Fumarate MDI and Symbicort Pressurized MDI in Adult and Adolescent Participants with Inadequately Controlled Asthma (KALOS) AstraZeneca  –  – on going
3 Dr. Jyothi Hattiholi     – Prospective, multi-centre, open-label, single-arm, clinical study to evaluate safety and efficacy of OmaliRelTM in patients with moderate to severe persistent asthma. Reliance Life Sciences  –  – on going
4 Dr. Jyothi Hattiholi     – Randomized double – Blind , Placebo Controlled , parallel-group Phase
III study to evaluate the safety and tolerability of
SAR440340/REGN3500/itepekimab (anti-IL-33 mAb) in patients with
moderate-to-severe chronic Obstructive Pulmonary Disease (COPD)
Sanofi  –  – on going
5 Dr. Jyothi Hattiholi     – A Phase III, multicentre, randomised, double-blind, chronic dosing, parallel group, placebo controlled extensions. Study to evaluate the long term efficacy and safety of Tozorakimab in participants with Chronic Obstructive Pulmonary Disease (COPD) with a history of exacerbations ( PROSPERO) AstraZeneca  –  – on going
6 Dr Gautam S     – A Phase 3, multicenter, randomized, double-blind, 24-week study
of the clinical and antiviral effect of S-217622 compared with
placebo in non-hospitalized participants with COVID-19
Shionogi  –  – on going
7 Dr. Jyothi Hattiholi   Protocol Title A Randomized, Single-dose, Double-blind, Double-dummy, Placebo and Active Controlled, Crossover Design Study Using Bronchoprovocation to Evaluate the Pharmacodynamic Equivalence of the Test and Reference Metered Dose Inhalers (MDIs) Containing Albuterol Sulfate in Adult Patients with Stable Mild Asthma. Intech Biopharm Ltd.  –  – on going
8 Dr. Jyothi Hattiholi   Reference: A Phase 3, 24-Week, Randomized, Double-Blind, Placebo-Controlled, Parallel-Arm
Efficacy and Safety Study with Open-label Extension of BLU-5937 in Adult Participants with Refractory Chronic Cough Including Unexplained Chronic Cough (CALM-2).
Bellus health Inc  –  – on going

 

International – Completed

Sl No Principal Investigator Co-Principal Investigator Title of the Project Funding Agency  Duration  (From-To)  Clinical Trial Registration Details  if any Status
1 Dr. M.V.Jali, Dr. Vinay Mahishale   Bidirectional screening of diabetes Mellitus and tuberculosis

1) Govt of India. 

2) WHO. 3) WDF.

4) International Union against Tuberculsosis and lung diseases.

Jan 2012 to Sept 2012 Completed

 

Industry Sponsored Clinical Trials – Completed

Sl No Principal Investigator Co-Principal Investigator Title of the Project Funding Agency  Duration  (From-To)  Clinical Trial Registration Details  if any Status
1 Dr. Vinay Mahishale   Roflimulast in COPD

Glenmark

Jan 2013 to June 2013 Completed

 

Completed

Sl No Research Scholar Guide Co-Guide Title of the Thesis  Duration  (From-To) 
1 Dr. Renu Pattenshetty Dr. G. S. Gaude   Effect of multimodality chest physiotherapy on the rate recovery and prevention of complications in patients with mechanical ventilation – a prospective study in medical and surgical intensive care units. 2007-2008
2 Dr. Ravi Saudatti Dr. G. S. Gaude   Comparative study of  postural correction and respiratory muscle training, and only respiratory muscle training in patients with chronic obstructive pulmonary diseases. 2007-2008